Researchers have made an appeal to gradient-boosting to establish decision tree machine learning libraries that could predict MDS development one year before the actual diagnosis, the transformation of MDS to AML, overall survival or complete remission, or inform about AML prognosis solely based on FLT3-ITD gene mutation status [14]. This evidence concerns the gene FLT3 and myelodysplastic syndrome.